drugset / Trial / NCT06307600
The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia
NaSingle-groupOpen-labelTreatment
Summary
This study is designed to explore the safety and efficacy for patients with relapsed and/or refractory B-cell lymphoblastic leukemia.
Timeline
- Start
- 2024-03-15
- Primary completion
- 2025-03-15
- Completion
- 2027-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RD06-03 | Cell therapy | 100000 cells/kg | Intravenous |
| Subject | RD06-03 | Cell therapy | 300000 cells/kg | Intravenous |
| Subject | RD06-03 | Cell therapy | 500000 cells/kg | Intravenous |